Published 4 years ago

Arizona COVID-19 Genomics Union tracks SARS-CoV-2 genome sequences

Summary by News Medical

Initial findings reported by the Arizona COVID-19 Genomics Union (ACGU) suggest that following Arizona's first reported case of COVID-19 in late January, the state experienced no cases that went undetected and was COVID-free until at least 11 distinct incursions occurred between mid-February and early April.

0 Articles

All

Left

Center

Right

Eurek Alert

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

(La Jolla Institute for Immunology) A multi-layered, virus-specific immune response is important for controlling SARS-CoV-2 during the acute phase of the infection and reducing COVID-19 disease severity, with the bulk of the evidence pointing to a much bigger role for T cells than antibodies. A weak or uncoordinated immune response, on the other hand, predicts a poor disease outcome.

4 years ago·Washington, United States

Read Full Article

News Medical

Arizona COVID-19 Genomics Union tracks SARS-CoV-2 genome sequences

4 years ago·United States

Read Full Article

Globe Newswire

ImmunoGenomics and Vero Diagnostics Providing COVID-19 Testing with Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay on Biomark HD Platform

Regional CLIA-Certified Labs among Growing Number of Customers Expanding SARS-CoV-2 Testing with Fluidigm Technology

4 years ago

Read Full Article

Nature

Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak

COVID-19 disease is less common in children than adults, but the extent to which SARS-CoV-2 infections are missed through symptom-driven testing is not well understood. In this study, the authors show that approximately 1% of children seeking care for reasons other than COVID-19 at a Seattle hospital in March/April 2020 were seropositive for SARS

4 years ago·United Kingdom

Read Full Article

Newswise

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

A multi-layered, virus-specific immune response is important for controlling SARS-CoV-2 during the acute phase of the infection and reducing COVID-19 disease severity, with the bulk of the evidence pointing to a much bigger role for T cells than antibodies.

4 years ago·Charlottesville, United States

Read Full Article

Gazeta Do Povo

Chinese virologist says Sars-CoV-2 was created in a laboratory

Chinese virologist Yan Li-Meng published an article, not peer-reviewed, on Monday (14) in which she concluded that Sars-CoV-2, the new coronavirus, was created in the laboratory. The position of the scientist, who was a researcher at the School of Public Health at the University of Hong Kong when she fled China after announcing her theory in the press, is contrary to the broad understanding of the scientific community that the virus arose in nat…

4 years ago·Curitiba, Brazil

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center4Last Updated4 years agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Arizona COVID-19 Genomics Union tracks SARS-CoV-2 genome sequences

0 Articles

0 Articles

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

Arizona COVID-19 Genomics Union tracks SARS-CoV-2 genome sequences

Arizona COVID-19 Genomics Union tracks SARS-CoV-2 genome sequences

ImmunoGenomics and Vero Diagnostics Providing COVID-19 Testing with Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay on Biomark HD Platform

ImmunoGenomics and Vero Diagnostics Providing COVID-19 Testing with Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay on Biomark HD Platform

Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak

Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

Chinese virologist says Sars-CoV-2 was created in a laboratory

Chinese virologist says Sars-CoV-2 was created in a laboratory

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics